| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |